Drug interactions
Bumetanide + Ipratropium-salbutamol
Severity: Moderate
Bumetanide and Ipratropium-salbutamol: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Both salbutamol and the loop diuretic bumetanide lower serum potassium. Combined use, particularly with high-dose or nebulized salbutamol, can cause clinically significant hypokalemia and increase arrhythmia risk.
What this interaction means in plain words
Bumetanide and Ipratropium-salbutamol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Bumetanide belongs to Cardiovascular; Ipratropium-salbutamol belongs to Respiratory.
Why it happens
Additive hypokalemia from beta-2 mediated cellular potassium uptake and renal potassium loss from loop diuretic.
What to do
Monitor serum potassium and magnesium and replace as needed. Take extra care in patients with heart disease, those on digoxin or receiving frequent high-dose salbutamol.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Bumetanide and Ipratropium-salbutamol, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Ipratropium-salbutamol
Other interactions of Bumetanide
Frequently asked questions
Can I take Bumetanide with Ipratropium-salbutamol?
MediHelp rates the interaction as moderate. Bumetanide and Ipratropium-salbutamol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both salbutamol and the loop diuretic bumetanide lower serum potassium. Combined use, particularly with high-dose or nebulized salbutamol, can cause clinically significant hypokalemia and increase arrhythmia risk.
How serious is the interaction between Bumetanide and Ipratropium-salbutamol?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum potassium and magnesium and replace as needed. Take extra care in patients with heart disease, those on digoxin or receiving frequent high-dose salbutamol.
What other medicines interact with Ipratropium-salbutamol?
MediHelp also lists interactions of Ipratropium-salbutamol with, for example, Amisulpride, Arsenic trioxide, Carvedilol. The full list is on the Ipratropium-salbutamol page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
